DEA schedule
Is deferasirox a controlled substance?
Federal schedule for deferasirox from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Deferasirox is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and deferasirox is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted deferasirox?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 94 prescription listings from 21 labelers, none with a DEA schedule |
| DEA controlled substances list | deferasirox is not on the list |
Deferasirox NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0078-0468 | Exjade | tablet, for suspension | 125 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0469 | Exjade | tablet, for suspension | 250 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0470 | Exjade | tablet, for suspension | 500 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0713 | Jadenu | granule | 180 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0720 | Jadenu | granule | 360 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0727 | Jadenu | granule | 90 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0655 | Jadenu | tablet, film coated | 180 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0656 | Jadenu | tablet, film coated | 360 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0654 | Jadenu | tablet, film coated | 90 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 31722-030 | DEFERASIROX | granule | 180 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 59651-448 | DEFERASIROX | granule | 180 mg/1 | Aurobindo Pharma Limited | None |
| 69097-560 | Deferasirox | granule | 180 mg/1 | Cipla USA Inc. | None |
| 31722-031 | DEFERASIROX | granule | 360 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 59651-449 | DEFERASIROX | granule | 360 mg/1 | Aurobindo Pharma Limited | None |
| 69097-570 | Deferasirox | granule | 360 mg/1 | Cipla USA Inc. | None |
| 31722-029 | DEFERASIROX | granule | 90 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 59651-447 | DEFERASIROX | granule | 90 mg/1 | Aurobindo Pharma Limited | None |
| 69097-550 | Deferasirox | granule | 90 mg/1 | Cipla USA Inc. | None |
| 43598-852 | Deferasirox | tablet | 180 mg/1 | Dr. Reddy's Laboratories Inc | None |
| 69539-074 | Deferasirox | tablet | 180 mg/1 | MSN LABORATORIES PRIVATE LIMITED | None |
| 70700-270 | Deferasirox | tablet | 180 mg/1 | Xiromed, LLC | None |
| 43598-851 | Deferasirox | tablet | 360 mg/1 | Dr. Reddy's Laboratories Inc | None |
| 69539-075 | Deferasirox | tablet | 360 mg/1 | MSN LABORATORIES PRIVATE LIMITED | None |
| 70700-271 | Deferasirox | tablet | 360 mg/1 | Xiromed, LLC | None |
| 73190-052 | Deferasirox | tablet | 360 mg/1 | AvKARE | None |
| 43598-853 | Deferasirox | tablet | 90 mg/1 | Dr. Reddy's Laboratories Inc | None |
| 69539-073 | Deferasirox | tablet | 90 mg/1 | MSN LABORATORIES PRIVATE LIMITED | None |
| 70700-269 | Deferasirox | tablet | 90 mg/1 | Xiromed, LLC | None |
| 31722-012 | Deferasirox | tablet, film coated | 180 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 46708-411 | DEFERASIROX | tablet, film coated | 180 mg/1 | Alembic Pharmaceuticals Limited | None |
| 59651-411 | DEFERASIROX | tablet, film coated | 180 mg/1 | Aurobindo Pharma Limited | None |
| 62332-411 | DEFERASIROX | tablet, film coated | 180 mg/1 | Alembic Pharmaceuticals Inc. | None |
| 67877-553 | Deferasirox | tablet, film coated | 180 mg/1 | Ascend Laboratories, LLC | None |
| 69238-1487 | Deferasirox | tablet, film coated | 180 mg/1 | Amneal Pharmaceuticals NY LLC | None |
| 70710-1276 | deferasirox | tablet, film coated | 180 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 70771-1472 | deferasirox | tablet, film coated | 180 mg/1 | Zydus Lifesciences Limited | None |
| 72603-232 | DEFERASIROX | tablet, film coated | 180 mg/1 | NorthStar Rx LLC | None |
| 31722-013 | Deferasirox | tablet, film coated | 360 mg/1 | Camber Pharmaceuticals, Inc. | None |
| 46708-412 | DEFERASIROX | tablet, film coated | 360 mg/1 | Alembic Pharmaceuticals Limited | None |
| 59651-412 | DEFERASIROX | tablet, film coated | 360 mg/1 | Aurobindo Pharma Limited | None |
Showing 40 of 94 listings.
Questions
Is deferasirox a controlled substance?
No. Deferasirox is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and deferasirox is not on the DEA controlled substances list.
Is deferasirox a narcotic?
No. Deferasirox is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Iron Chelator.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.